Martha Lucia Serrano
Overview
Explore the profile of Martha Lucia Serrano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acosta-Vega N, Varela R, Mesa J, Garai J, Baddoo M, Gomez-Gutierrez A, et al.
Cancer Med
. 2022 Nov;
12(4):4306-4320.
PMID: 36329628
Background: The role of ERG-status molecular subtyping in prognosis of prostate cancer (PCa) is still under debate. In this study, we identified differentially expressed genes (DEGs) according to ERG-status to...
2.
Segura-Moreno Y, Sanabria-Salas M, Mesa-Lopez De Mesa J, Varela-Ramirez R, Acosta-Vega N, Serrano M
Cancer Rep (Hoboken)
. 2022 Oct;
6(2):e1728.
PMID: 36199157
Background: The prognostic relevance of prostate cancer (PCa) molecular subtypes remains controversial, given the presence of multiple foci with the possibility of different subtypes in the same patient. Aim: To...
3.
Morales-Suarez P, Montero-Ovalle W, Pardo-Sanabria P, Cuestas-Castaneda J, Segura-Moreno Y, Nunez-Lemus M, et al.
J Cancer Educ
. 2022 Oct;
38(3):1000-1009.
PMID: 36183277
In Colombia, prostate cancer (PCa) is the most common cancer for incidence and mortality in men, which turns it into a public health problem. For high-risk communities to better understand...
4.
Herrera-Pulido J, Ricaurte Guerrero O, Forero J, Moreno-Acosta P, Romero-Rojas A, Sanabria C, et al.
Cancer Diagn Progn
. 2022 Sep;
2(5):576-584.
PMID: 36060016
Background/aim: Although some mutations of KRAS proto-oncogene, GTPase (KRAS) have been associated with the prognosis and therapeutic management of colorectal cancer (CRC), the epigenetic mechanisms (DNA methylation and microRNA expression)...
5.
Segura-Moreno Y, Sanabria-Salas M, Varela R, Mesa J, Serrano M
Oncol Lett
. 2021 Mar;
21(5):376.
PMID: 33777200
Prostate cancer (PCa) is characterized as being histologically and molecularly heterogeneous; however, this is not only incorrect among individuals, but also at the multiple foci level, which originates in the...
6.
Ardila H, Sanabria-Salas M, Meneses X, Rios R, Huertas-Salgado A, Serrano M
Mol Clin Oncol
. 2019 Jul;
11(2):201-207.
PMID: 31316774
Colorectal cancer (CRC) is one of the prominent causes of cancer related deaths because, in part, there is not an early, non-invasive, effective detection strategy. Circulating microRNAs (miRNAs) have been...
7.
Serrano M, Yunis J
Biomedica
. 2013 May;
33(1):53-61.
PMID: 23715307
Introduction: Retinoblastoma is a childhood cancer of the retina originated by altered or null retinoblastoma protein (pRb) expression. Genetic alterations in both RB1 alleles in the retinal cells are required...
8.
Rodriguez J, Galeano L, Palacios D, Gomez C, Serrano M, Mercedes Bravo M, et al.
Pathobiology
. 2012 Jan;
79(2):72-83.
PMID: 22213066
Although high-risk human papillomaviruses (HPVs) are an important risk factor in the etiopathogenesis of cervical cancer, increasing evidence suggests that the ability to avoid immune surveillance seems to be linked...
9.
Serrano M, Romero A, Cendales R, Sanchez-Gomez M, Mercedes Bravo M
Biomedica
. 2006 Aug;
26(2):258-68.
PMID: 16925098
Introduction: Pap smear has limitations as a screening test for cervical cancer. A marker that allows the identification of women who are at risk of developing cervical cancer would be...